Cover Image
市場調查報告書

纖維肉瘤:全球臨床實驗檢討

Fibrosarcoma Global Clinical Trials Review, H1, 2014

出版商 GlobalData 商品編碼 297517
出版日期 內容資訊 英文 104 Pages
訂單完成後即時交付
價格
Back to Top
纖維肉瘤:全球臨床實驗檢討 Fibrosarcoma Global Clinical Trials Review, H1, 2014
出版日期: 2014年03月12日 內容資訊: 英文 104 Pages
簡介

本報告提供纖維肉瘤的治療藥相關臨床實驗調查分析,提供臨床實驗數及被實驗人數,Phase別及各方面狀況,有潛力的企業,正在開發的治療藥的資訊,臨床實驗簡介等,為您概述為以下內容。

目錄

簡介

各地區的臨床實驗

  • 各國臨床實驗趨勢
    • 亞太地區的主要國家
    • 歐洲的主要國家
    • 北美的主要國家
    • 中東·非洲的主要國家

G7各國的臨床實驗:腫瘤科臨床實驗中纖維肉瘤的比例

G7各國的臨床實驗:Phase別

G7各國的臨床實驗:階段別

各方面的臨床實驗

Phase別臨床實驗

評估項目別臨床實驗

未完成的臨床實驗

一定期間所採用的實驗對象

贊助商各類型臨床實驗

有潛力的贊助商

  • 參與纖維肉瘤治療藥臨床實驗的主要企業

有前途藥物

最新臨床實驗新聞

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Novartis AG
    • Oncolytics Biotech Inc.
    • 第一三共
    • Celgene Corporation
  • 主要大學·研究機關·醫院臨床實驗概要
    • National Cancer Institute
    • Children's Oncology Group
    • Memorial Sloan Kettering Cancer Center
    • Societe Internationale d'Oncologie Pediatrique
    • Massachusetts General Hospital
    • Assistance Publique - Hopitaux de Paris
    • National Taiwan University Hospital
    • University of Michigan Comprehensive Cancer Center
    • Albert Einstein College of Medicine of Yeshiva University

主要的臨床簡介

附錄

圖表

目錄
Product Code: GDHC2029CTIDB

GlobalData's clinical trial report, "Fibrosarcoma Global Clinical Trials Review, H1, 2014" provides data on the Fibrosarcoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Fibrosarcoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Fibrosarcoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Fibrosarcoma
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Fibrosarcoma to Oncology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Fibrosarcoma
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Fibrosarcoma Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • Oncolytics Biotech Inc.
      • Clinical Trial Overview of Oncolytics Biotech Inc.
      • Daiichi Sankyo Company, Limited
      • Clinical Trial Overview of Daiichi Sankyo Company, Limited
      • Celgene Corporation
      • Clinical Trial Overview of Celgene Corporation
    • Clinical Trial Overview of Top Institutes / Government
      • National Cancer Institute
      • Clinical Trial Overview of National Cancer Institute
      • Children's Oncology Group
      • Clinical Trial Overview of Children's Oncology Group
      • Memorial Sloan Kettering Cancer Center
      • Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
      • Societe Internationale d'Oncologie Pediatrique
      • Clinical Trial Overview of Societe Internationale d'Oncologie Pediatrique
      • Massachusetts General Hospital
      • Clinical Trial Overview of Massachusetts General Hospital
      • Assistance Publique - Hopitaux de Paris
      • Clinical Trial Overview of Assistance Publique - Hopitaux de Paris
      • National Taiwan University Hospital
      • Clinical Trial Overview of National Taiwan University Hospital
      • University of Michigan Comprehensive Cancer Center
      • Clinical Trial Overview of University of Michigan Comprehensive Cancer Center
      • Albert Einstein College of Medicine of Yeshiva University
      • Clinical Trial Overview of Albert Einstein College of Medicine of Yeshiva University
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Fibrosarcoma Therapeutics, Global, Clinical Trials by Region, 2014*
  • Fibrosarcoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Fibrosarcoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Fibrosarcoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014*
  • Fibrosarcoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Fibrosarcoma Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Fibrosarcoma Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Fibrosarcoma to Oncology Clinical Trials, G7 Countries (%), 2014*
  • Fibrosarcoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Fibrosarcoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Fibrosarcoma Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Fibrosarcoma Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Fibrosarcoma Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Fibrosarcoma Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Fibrosarcoma Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Fibrosarcoma Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Fibrosarcoma Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Fibrosarcoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Fibrosarcoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Fibrosarcoma Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Fibrosarcoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Fibrosarcoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Fibrosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014*
  • Fibrosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Oncolytics Biotech Inc., 2014*
  • Fibrosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2014*
  • Fibrosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2014*
  • Fibrosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014*
  • Fibrosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Oncology Group, 2014*
  • Fibrosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014*
  • Fibrosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Societe Internationale d'Oncologie Pediatrique, 2014*
  • Fibrosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2014*
  • Fibrosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2014*
  • Fibrosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2014*
  • Fibrosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan Comprehensive Cancer Center, 2014*
  • Fibrosarcoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Albert Einstein College of Medicine of Yeshiva University, 2014*

List of Figures

  • Fibrosarcoma Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Fibrosarcoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Fibrosarcoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Fibrosarcoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014*
  • Fibrosarcoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Fibrosarcoma Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Fibrosarcoma Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014*
  • Proportion of Fibrosarcoma to Oncology Clinical Trials, G7 Countries (%), 2014*
  • Fibrosarcoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Fibrosarcoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Fibrosarcoma Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Fibrosarcoma Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Fibrosarcoma Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Fibrosarcoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Fibrosarcoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Fibrosarcoma Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Fibrosarcoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Fibrosarcoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top